GYRE(GYRE)
GYRE
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $110M | $140M | $436M | $265M | $309M |
| Low | $109M | $135M | $421M | $256M | $298M |
| High | $110M | $144M | $451M | $274M | $320M |
| EBITDA Avg | $-9M | $-11M | $-35M | $-21M | $-25M |
| Low | $-9M | $-12M | $-36M | $-22M | $-26M |
| High | $-9M | $-11M | $-34M | $-21M | $-24M |
| EBIT Avg | $-10M | $-13M | $-40M | $-24M | $-29M |
| Low | $-10M | $-13M | $-42M | $-25M | $-30M |
| High | $-10M | $-12M | $-39M | $-24M | $-28M |
| Net Income Avg | $-41M | $-24M | $182M | $34M | $48M |
| Low | $-43M | $-25M | $173M | $33M | $46M |
| High | $-39M | $-23M | $190M | $36M | $51M |
| EPS Avg | $-0.40 | $-0.23 | $1.76 | $0.33 | $0.47 |
| Low | $-0.42 | $-0.25 | $1.68 | $0.32 | $0.45 |
| High | $-0.38 | $-0.22 | $1.84 | $0.34 | $0.49 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $28M | $30M |
| Low | $28M | $29M |
| High | $29M | $30M |
| EBITDA Avg | $-2M | $-2M |
| Low | $-2M | $-2M |
| High | $-2M | $-2M |
| EBIT Avg | $-3M | $-3M |
| Low | $-3M | $-3M |
| High | $-3M | $-3M |
| Net Income Avg | $-12M | $-12M |
| Low | $-15M | $-15M |
| High | $-8M | $-8M |
| EPS Avg | $-0.12 | $-0.12 |
| Low | $-0.15 | $-0.15 |
| High | $-0.08 | $-0.08 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |